Company Number: 14402580

Analysis Date: 2025-07-20 14:11 UTC

Financial Health Assessment
Company: RELIANCE BIOTECH CONSULTANCY LTD
Date of Assessment: Financial year ending 31 October 2023

---

1. Financial Health Score: Grade D

Explanation:
The company is classified as dormant with minimal financial activity, reflected in extremely low asset levels (£5 current assets) and no liabilities. While this indicates no immediate financial distress, the company shows no operational revenue or expenses, which signals an absence of business activity or cash flow. The financial "vital signs" are stable but essentially flatlined, meaning the company is not currently generating or using resources to grow or sustain operations.

---

2. Key Vital Signs

Metric	Value	Interpretation
Company Status	Active	Registered and operational on record
Account Category	Dormant	No significant financial transactions
Current Assets	£5	Minimal liquid resources; negligible cash
Current Liabilities	£0	No short-term debts; no financial obligations
Net Current Assets	£5	Positive but trivial working capital
Net Assets	£5	Total equity matches net current assets
Shareholders’ Funds	£5	Equity invested, no retained earnings
Employees	0	No active workforce; no payroll expenses
Filing Status	Up to date	No overdue accounts or returns

Interpretation:
The company’s balance sheet shows virtually no activity — like a patient with a resting heart rate but no pulse of business operations. The absence of liabilities is positive, but the lack of assets and revenue-generating activity suggests the business is in a state of dormancy or "hibernation," without active financial life signs such as turnover, profit, or investment.

---

3. Diagnosis

Overall Financial Condition:
RELIANCE BIOTECH CONSULTANCY LTD is currently a dormant company with no operational activity during its first financial year. The balance sheet is essentially a snapshot of an inert entity with negligible financial resources and no business transactions. There are no warning signs of financial distress since there are no debts or obligations, but equally, there are no signs of growth, cash inflows, or financial vitality.

This condition is typical for newly formed companies that have not yet commenced trading or are holding dormant status, possibly for future use or as a placeholder entity.

Symptoms Analysis:

• Lack of revenue and expenses indicates no trading activity.
• Minimal current assets suggest no cash or receivables.
• Zero employees confirm no operational workforce or payroll.
• Up-to-date filings show regulatory compliance, a positive governance sign.
• Directors are in place, but no indication of active management or business development.

---

4. Prognosis

Future Financial Outlook:
Unless the company transitions from dormant to active trading, its financial health will remain flat, with minimal asset accumulation or revenue generation. This "steady but inert" state means no financial risks currently but also no growth prospects.

If the business plans to commence operations, initial cash injections, asset acquisitions, or cost outlays will be necessary to stimulate financial "heartbeat" and generate sustainable cash flow. Without these, the company risks prolonged dormancy or eventual dissolution.

---

5. Recommendations

• Activate Trading Operations: To move from dormancy to a financially healthy state, the company should initiate business activities, generating revenue and incurring operational expenses to build working capital.
• Capital Injection: Consider increasing equity or securing initial funding to support business startup costs and working capital needs.
• Financial Planning: Develop a detailed business plan with budgets and cash flow forecasts to monitor financial "vital signs" closely as operations commence.
• Regular Monitoring: Maintain timely filings and compliance to avoid regulatory penalties, preserving company "health."
• Engage Financial Expertise: Seek financial advice to structure accounts and optimize tax positions once trading begins.

---